{"news_desk": "Business", "print_page": "2", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By KATIE THOMAS", "person": [{"rank": 1, "role": "reported", "firstname": "Katie", "organization": "", "lastname": "THOMAS"}]}, "abstract": "Valeant Pharmaceuticals chief executive Joseph C Papa tells analysts that he is optimistic about company's future; company reports loss of almost $374 million in first quarter, revealing troubles in its core business areas.", "type_of_material": "News", "word_count": "797", "lead_paragraph": "Valeant, the pharmaceuticals company facing questions about its business and accounting practices, said it lost nearly $374 million in the quarter.", "pub_date": "2016-06-08T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Valeant Reports First-Quarter Loss and Cuts Its Forecast", "print_headline": "Valeant Reports First-Quarter Loss as Chief Assures Bright Future"}, "snippet": "Valeant, the pharmaceuticals company facing questions about its business and accounting practices, said it lost nearly $374 million in the quarter.", "multimedia": [{"height": 126, "url": "images/2016/06/08/business/08valeant/08valeant-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2016/06/08/business/08valeant/08valeant-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2016/06/08/business/08valeant/08valeant-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2016/06/08/business/08valeant/08valeant-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2016/06/08/business/08valeant/08valeant-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/06/08/business/08valeant/08valeant-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2016/06/08/business/valeant-q1-earnings.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Papa, Joseph C", "name": "persons"}, {"rank": "3", "is_major": "N", "value": "Company Reports", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}], "blog": [], "_id": "5756d0a038f0d839b19249f9", "source": "The New York Times"}